Improving the efficiency of the formalin test
- PMID: 10568865
- DOI: 10.1016/S0304-3959(99)00168-2
Improving the efficiency of the formalin test
Abstract
A time-sampling method that allows up to eight rats to be tested simultaneously in the formalin test is described and compared to the continuous rating method. Time sampling the behavioural response to formalin every 1 or 2 min produces scores that are essentially identical to continuous rating for both the formalin concentration effect relationship and the morphine dose effect relationship, with no loss of statistical power. The most important advantage of the method is that it allows data on other aspects of the rats' behaviour, such as behavioural state and the side effects of drugs to be scored during the formalin test. Formalin injection produces a dose-dependent decrease in locomotor and exploratory activity. The activity pattern of rats is normalized at morphine doses that produce about a 50% reduction in pain, while morphine doses high enough to completely suppress the pain response are accompanied by considerable sedation. The use of the jackknifing procedure to obtain unbiased estimates of the variability of parameters estimated from dose effect relationships is also described.
References
-
- Abbott FV, Guy ER. Effects of morphine, pentobarbital and amphetamine on formalin-induced behaviours in infant rats: sedation versus specific suppression of pain. Pain 1995;62:303-312.
-
- Abbott FV, Franklin KBJ, Westbrook RF. The formalin test: scoring properties of first and second phases of the pain response in rats. Pain 1995;60:91-102.
-
- Abbott FV. β-Funaltrexamine antagonizes the analgesic effects of μ and k agonists in the formalin test. Pharmacol Biochem Behav 1991;37:713-716.
-
- Aloisi AM, Porro CA, Cavazzuti M, Baraldi P, Carli G. ‘Mirror pain’ in the formalin test: behavioral and 2-deoxyglucose studies. Pain 1993;55:267-273.
-
- Bannon AW, Decker MW, Curzon P, Buckley MJ, Kim DJ, Radek RJ, Lynch JK, Wasicak JT, Lin NH, Arnold WH, Holladay MW, Williams M, Arneric SP. ABT594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization. J Pharmacol Exp Ther 1998;285:787-794.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
